Alpha 2.0
Login Register
» Articles » PMID: 19465221

Ranking Antidepressants

Overview
Journal Lancet
Publisher Elsevier
Specialty General Medicine
Date 2009 May 26
PMID 19465221
Citations 9
Authors
John P A Ioannidis
Affiliations
Soon will be listed here.
Citing Articles

Can we well assess the relative efficacy and tolerability of a new drug versus others at the time of marketing authorization using mixed treatment comparisons? A detailed illustration with escitalopram.

Llorca P, Lancon C, Brignone M, Painchault C, Rive B, Toumi M J Mark Access Health Policy. 2016; 3.

PMID: 27123184 PMC: 4802698. DOI: 10.3402/jmahp.v3.26776.

From Randomized Controlled Trials of Antidepressant Drugs to the Meta-Analytic Synthesis of Evidence: Methodological Aspects Lead to Discrepant Findings.

Fountoulakis K, McIntyre R, Carvalho A Curr Neuropharmacol. 2015; 13(5):605-15.

PMID: 26467410 PMC: 4761632. DOI: 10.2174/1570159x13666150630174343.

Ranking treatments in frequentist network meta-analysis works without resampling methods.

Rucker G, Schwarzer G BMC Med Res Methodol. 2015; 15:58.

PMID: 26227148 PMC: 4521472. DOI: 10.1186/s12874-015-0060-8.

Which placebo to cure depression? A thought-provoking network meta-analysis.

Naudet F, Millet B, Charlier P, Reymann J, Maria A, Falissard B BMC Med. 2013; 11:230.

PMID: 24160565 PMC: 3819667. DOI: 10.1186/1741-7015-11-230.

The effects of excluding treatments from network meta-analyses: survey.

Mills E, Kanters S, Thorlund K, Chaimani A, Veroniki A, Ioannidis J BMJ. 2013; 347:f5195.

PMID: 24009242 PMC: 3763846. DOI: 10.1136/bmj.f5195.